P1.03-19 Antibody Blockade of Integrin Alpha-V-Beta-6 (Avb6) as a Novel Treatment for NSCLC

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.700
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Truncated Bovine Integrin Alpha-v/Beta-6 as a Universal Capture Ligand for FMD Diagnosis

PLoS ONE
Multidisciplinary
2016English

A Monoclonal Antibody Against an Activation Epitope on Mouse Integrin Chain Beta 1 Blocks Adhesion of Lymphocytes to the Endothelial Integrin Alpha 6 Beta 1.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1993English

Integrin Alpha v Beta 5 Selectively Promotes Adenovirus Mediated Cell Membrane Permeabilization

Journal of Cell Biology
MedicineCell Biology
1994English

A Novel Integrin Specificity Exemplified by Binding of the Alpha v Beta 5 Integrin to the Basic Domain of the HIV Tat Protein and Vitronectin

Journal of Cell Biology
MedicineCell Biology
1993English

Alpha- And Beta-Adrenergic Receptor Blockade in the Treatment of Hypertension.

Heart
Cardiovascular MedicineCardiology
1974English

P1.03-24 TMPRSS4: A Novel Prognostic Biomarker and Therapeutic Target in NSCLC

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Identification by Differential Display of Alpha 6 Integrin as a Candidate Tumor Suppressor Gene.

FASEB Journal
BiochemistryBiotechnologyGeneticsMolecular BiologyMedicine
1993English

Critical Role for v 6 Integrin in Enamel Biomineralization

Journal of Cell Science
Cell Biology
2012English

A Novel Beta 4, Alpha 6 Integrin-Associated Epithelial Cell Antigen Involved in Natural Killer Cell and Antigen-Specific Cytotoxic T Lymphocyte Cytotoxicity

Journal of Experimental Medicine
MedicineAllergyImmunology
1991English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy